Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of lesinurad monotherapy in gout
2011-003756-39Phase 3Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gout comparing Lesinurad with Placebo (2 arms). Primary endpoint: Proportion of subjects with serum uric acid < 6.0 mg/dL at Month 6. Started Jan 2012; status: completed.
02
Drugs
lesinurad
03
Conditions
gout
Beyond the preview
Go deeper on 2011-003756-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003756-39.